exoderil 10 mg/g krema
lek d.d. - niftifin - krema - niftifin 8,9 mg / 1 g - naftifin
exoderil 10 mg/g krema
lek d.d. - niftifin - krema - niftifin 8,9 mg / 1 g - naftifin
fetimin
krema - naftifin
cresemba
basilea pharmaceutica deutschland gmbh - isavukonazol - aspergiloza - cresemba je navedeno pri odraslih za zdravljenje:invazivne aspergillosismucormycosis pri bolnikih, za katere amphotericin b je inappropriateconsideration treba uradna smernice za ustrezno uporabo protiglivično agenti.
lojuxta
amryt pharmaceuticals dac - lomitapide - hiperholesterolemija - sredstva za spreminjanje lipidov - lojuxta je navedena kot dodatek k dieti low‑fat in drugimi lipid‑lowering zdravili z ali brez citofereza nizko gostoto lipoproteinov (ldl), pri odraslih bolnikih s homozigotno družinsko hiperholesterolemijo (hofh). genetske potrditev hofh, je treba pridobiti, kadar je to mogoče. druge oblike primarne hyperlipoproteinaemia in sekundarne vzroke hypercholesterolaemia (e. nephrotic sindrom, hipotiroidizem) mora biti izključena.
pifeltro
merck sharp & dohme b.v. - doravirine - okužbe z virusom hiv - antivirusi za sistemsko uporabo - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.
ciklosporin alkaloid-int 100 mg/ml peroralna raztopina
alkaloid - int d.o.o. - ciklosporin - peroralna raztopina - ciklosporin 100 mg / 1 ml - ciklosporin
ciklosporin alkaloid-int 25 mg mehke kapsule
alkaloid - int d.o.o. - ciklosporin - kapsula, mehka - ciklosporin 25 mg / 1 kapsula - ciklosporin
ciklosporin alkaloid-int 50 mg mehke kapsule
alkaloid - int d.o.o. - ciklosporin - kapsula, mehka - ciklosporin 50 mg / 1 kapsula - ciklosporin
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastična sredstva - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).